10x Genomics (TXG) Earnings Date, Estimates & Call Transcripts → Urgent Alert: Is the U.S. Implementing a Digital Dollar? (From Gold Gate Capital) (Ad) Free TXG Stock Alerts $27.15 -0.10 (-0.37%) (As of 09:06 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (Apr. 30) -$0.50 Consensus EPS (Apr. 30) -$0.50 Read Call TranscriptListen to Call Get 10x Genomics Earnings AlertsEnter your email address below to receive the latest news and earnings results for TXG and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTXG Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TXG Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad American Hartford Gold GroupDave Ramsey Shocks Millions With US Dollar LunacyDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE 10x Genomics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ2 20241($0.53)($0.53)($0.53) Q3 20241($0.41)($0.41)($0.41) Q4 20241($0.30)($0.30)($0.30) TXG Earnings Date and Information10x Genomics last announced its quarterly earnings results on April 30th, 2024. The reported ($0.50) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.50). The business earned $141.01 million during the quarter, compared to the consensus estimate of $142.24 million. Its revenue for the quarter was up 5.0% on a year-over-year basis. 10x Genomics has generated ($2.23) earnings per share over the last year (($2.23) diluted earnings per share). Earnings for 10x Genomics are expected to grow in the coming year, from ($1.55) to ($0.90) per share. 10x Genomics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More 10x Genomics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024Estimated)------- 4/30/2024Q1 2024($0.50)($0.50)-($0.50)$142.24 million$141.01 million 2/15/2024Q4 2023($0.36)($0.41)($0.05)($0.41)$182.73 million$183.98 million 11/2/2023Q3 2023($0.45)($0.51)($0.06)($0.23)$150.11 million$153.64 million8/3/2023Q2 2023($0.39)($0.53)($0.14)($0.53)$139.97 million$146.82 million 5/3/2023Q1 2023($0.38)($0.44)($0.06)($0.44)$128.87 million$134.29 million 2/15/2023Q4 2022($0.29)($0.15)+$0.14($0.15)$148.17 million$156.20 million Get the Latest News and Ratings for TXG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 10x Genomics and its competitors with MarketBeat's FREE daily newsletter. 11/2/2022Q3 2022($0.45)($0.37)+$0.08($0.37)$129.13 million$131.10 million 8/8/2022Q2 2022($0.40)($0.57)($0.17)($0.57)$115.89 million$114.61 million 5/4/2022Q1 2022($0.37)($0.38)($0.01)($0.38)$113.33 million$114.50 million 2/16/2022Q4 2021($0.06)($0.16)($0.10)($0.16)$148.50 million$143.53 million 11/3/2021Q3 2021($0.18)($0.15)+$0.03($0.15)$124.07 million$125.30 million 8/3/2021Q2 2021($0.26)($0.10)+$0.16($0.10)$112.85 million$115.84 million 10x Genomics Earnings - Frequently Asked Questions When is 10x Genomics's earnings date? 10x Genomics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on TXG's earnings history. Did 10x Genomics beat their earnings estimates last quarter? In the previous quarter, 10x Genomics (NASDAQ:TXG) reported ($0.50) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.50). Learn more on analysts' earnings estimate vs. TXG's actual earnings. How can I listen to 10x Genomics's earnings conference call? The conference call for 10x Genomics's latest earnings report can be listened to online. Listen to Conference Call How can I read 10x Genomics's conference call transcript? The conference call transcript for 10x Genomics's latest earnings report can be read online. Read Transcript How much revenue does 10x Genomics generate each year? 10x Genomics (NASDAQ:TXG) has a recorded annual revenue of $618.73 million. How much profit does 10x Genomics generate each year? 10x Genomics (NASDAQ:TXG) has a recorded net income of -$255.10 million. TXG has generated -$2.23 earnings per share over the last four quarters. What is 10x Genomics's EPS forecast for next year? 10x Genomics's earnings are expected to grow from ($1.55) per share to ($0.90) per share in the next year. More Earnings Resources from MarketBeat Related Companies: OLK Earnings Results EYPT Earnings Results BIO.B Earnings Results BIO Earnings Results BRKR Earnings Results RVTY Earnings Results AXSM Earnings Results RARE Earnings Results CRNX Earnings Results SWTX Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Tech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat This page (NASDAQ:TXG) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyDollar CancelledLear CapitalUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate CapitalDave Ramsey Shocks Millions With US Dollar LunacyAmerican Hartford Gold GroupTrump is sounding the alarmPreserve GoldBiden’s Sneaky H.R. 5376 Is A Nightmare For Retirement SaversBirch GoldIs Tesla going out of business?DTIAI “wealth window” is closing June 25thParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
